Solventum Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SOLV | 0QMV.IL | MDLN | AVTR | XRAY | NVST | |
|---|---|---|---|---|---|---|
| Market cap | 15.21B | 17.73B | 54.29B | 10.60B | 2.12B | 4.37B |
| P/E (TTM) | 10.9 | 45.2 | 91.7 | 31.3 | — | 46.9 |
| Forward P/E | 12.3 | — | 25.7 | 17.6 | 7.2 | 16.4 |
| Price/book | 3.2 | 8.9 | 3.0 | 1.8 | 1.6 | 1.4 |
| Dividend yield | — | 0.72% | — | — | — | — |
| 1-year change | +25.22% | +3.75% | −16.85% | +34.63% | −22.90% | +22.93% |
| Today | +5.42% | −1.12% | +18.36% | +0.38% | +9.46% | +9.77% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All SOLV news ›Solventum (SOLV) Q3 earnings report preview: what to look for
Healthcare solutions provider Solventum SOLVwill be reporting earnings this Thursday after the bell. Here’s what investors should know. Solventum beat analysts’ revenue expectations last quarter, reporting revenues of $2.21 billion, up…
Analysts Conflicted on These Healthcare Names: Solventum Corporation (SOLV), HCA Healthcare (HCA) and Immunocore Holdings (IMCR)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Solventum Corporation (SOLV), HCA Healthcare (HCA) and Immunocore Holdings (IMCR). In a report released yesterday, Travis Steed from Bank of…
FDA clears Solventum’s combo wound care platform following Acera acquisition
October 22, 2026 By Conor Hale Solventum will now pair Restrata with its V.A.C. negative pressure wound therapy, to help create a local environment that further promotes wound healing and maintains close contact between the fiber matrix…
Shrieve Chemical Acquires RSG to Expand Solvent Business
Shrieve Chemical Company, a leading global distributor of specialized chemicals, has acquired Research Solutions Group, Inc. (RSG), strengthening its industrial solvent business and expanding its presence across the Southeastern United…
Solventum Unveils Next-Generation Filtek Matrix Restorative System
New system is designed to help practices deliver predictable, aesthetic and conservative composite restorations. Designed to help clinicians deliver conservative anterior restorations more predictably, the new Solventum Filtek Matrix…
FDA Clears Combined Use of Restrata Matrix With Solventum V.A.C. Therapy
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends. FDA Clears Combined Use of Restrata Matrix With Solventum V.A.C.…
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
AOL.com EAGAN, Minn., Oct. 15, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter fiscal 2026 financial results on Thursday, November 5, 2026, after the U.S. financial markets close. Following the rele
Solventum collecting offers for Health Information Systems Business - Axios Pro
Solventum (SOLV), 3M’s spinoff, seeks bids for its Health Information Systems unit at a $5.5B–$7B valuation—get the latest deal update now. Solventum (SOLV), the 3M (MMM) spinoff that manufactures medical products and technology, is…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- tradingview.com2
- aol.com1
- chemanalyst.com1
- massdevice.com1
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.